Cargando…
The Role of Prostatitis in Prostate Cancer: Meta-Analysis
OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, wer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877315/ https://www.ncbi.nlm.nih.gov/pubmed/24391995 http://dx.doi.org/10.1371/journal.pone.0085179 |
_version_ | 1782297624585437184 |
---|---|
author | Jiang, Junyi Li, Jinyi Yunxia, Zhang Zhu, Hong Liu, Junjiang Pumill, Chris |
author_facet | Jiang, Junyi Li, Jinyi Yunxia, Zhang Zhu, Hong Liu, Junjiang Pumill, Chris |
author_sort | Jiang, Junyi |
collection | PubMed |
description | OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, were collected to calculate a pooled odds ratio. Selection criteria: the selection criteria are as follows: human case control studies; published from May 1990 to July 2012; containing number of prostatitis, and prostate cancer cases. EVIDENCE SYNTHESIS: In total, 20 case control studies were included. A significant association between prostatitis and prostate cancer was found, under both fixed effect model (pooled OR=1.50, 95%CI: 1.39-1.62), and random effects model (OR=1.64, 95%CI: 1.36-1.98). Personal interview based case control studies showed a high level of association (fixed effect model: pooled OR=1.59, 95%CI: 1.47-1.73, random effects model: pooled OR= 1.87, 95%CI: 1.52-2.29), compared with clinical based studies (fixed effect model: pooled OR=1.05, 95%CI: 0.86-1.28, random effects model: pooled OR= 0.98, 95%CI: 0.67-1.45). Additionally, pooled ORs, were calculated for each decade. In a fixed effect model: 1990’s: OR=1.58, 95% CI: 1.35-1.84; 2000’s: OR=1.59, 95% CI: 1.40-1.79; 2010’s: OR=1.37, 95% CI: 1.22-1.56. In a random effects model: 1990’s: OR=1.98, 95% CI: 1.08-3.62; 2000’s: OR=1.64, 95% CI: 1.23-2.19; 2010’s: OR=1.34, 95% CI: 1.03-1.73. Finally a meta-analysis stratified by each country was conducted. In fixed effect models, U.S: pooled OR =1.45, 95%CI: 1.34-1.57; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. In random effects model, U.S: pooled OR=1.50, 95%CI: 1.25-1.80; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90.CONCLUSIONS: the present meta-analysis provides the statistical evidence that the association between prostatitis and prostate cancer is significant. |
format | Online Article Text |
id | pubmed-3877315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38773152014-01-03 The Role of Prostatitis in Prostate Cancer: Meta-Analysis Jiang, Junyi Li, Jinyi Yunxia, Zhang Zhu, Hong Liu, Junjiang Pumill, Chris PLoS One Research Article OBJECTIVE: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. EVIDENCE ACQUISITION: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, were collected to calculate a pooled odds ratio. Selection criteria: the selection criteria are as follows: human case control studies; published from May 1990 to July 2012; containing number of prostatitis, and prostate cancer cases. EVIDENCE SYNTHESIS: In total, 20 case control studies were included. A significant association between prostatitis and prostate cancer was found, under both fixed effect model (pooled OR=1.50, 95%CI: 1.39-1.62), and random effects model (OR=1.64, 95%CI: 1.36-1.98). Personal interview based case control studies showed a high level of association (fixed effect model: pooled OR=1.59, 95%CI: 1.47-1.73, random effects model: pooled OR= 1.87, 95%CI: 1.52-2.29), compared with clinical based studies (fixed effect model: pooled OR=1.05, 95%CI: 0.86-1.28, random effects model: pooled OR= 0.98, 95%CI: 0.67-1.45). Additionally, pooled ORs, were calculated for each decade. In a fixed effect model: 1990’s: OR=1.58, 95% CI: 1.35-1.84; 2000’s: OR=1.59, 95% CI: 1.40-1.79; 2010’s: OR=1.37, 95% CI: 1.22-1.56. In a random effects model: 1990’s: OR=1.98, 95% CI: 1.08-3.62; 2000’s: OR=1.64, 95% CI: 1.23-2.19; 2010’s: OR=1.34, 95% CI: 1.03-1.73. Finally a meta-analysis stratified by each country was conducted. In fixed effect models, U.S: pooled OR =1.45, 95%CI: 1.34-1.57; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. In random effects model, U.S: pooled OR=1.50, 95%CI: 1.25-1.80; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90.CONCLUSIONS: the present meta-analysis provides the statistical evidence that the association between prostatitis and prostate cancer is significant. Public Library of Science 2013-12-31 /pmc/articles/PMC3877315/ /pubmed/24391995 http://dx.doi.org/10.1371/journal.pone.0085179 Text en © 2013 Jiang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jiang, Junyi Li, Jinyi Yunxia, Zhang Zhu, Hong Liu, Junjiang Pumill, Chris The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title | The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title_full | The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title_fullStr | The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title_full_unstemmed | The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title_short | The Role of Prostatitis in Prostate Cancer: Meta-Analysis |
title_sort | role of prostatitis in prostate cancer: meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877315/ https://www.ncbi.nlm.nih.gov/pubmed/24391995 http://dx.doi.org/10.1371/journal.pone.0085179 |
work_keys_str_mv | AT jiangjunyi theroleofprostatitisinprostatecancermetaanalysis AT lijinyi theroleofprostatitisinprostatecancermetaanalysis AT yunxiazhang theroleofprostatitisinprostatecancermetaanalysis AT zhuhong theroleofprostatitisinprostatecancermetaanalysis AT liujunjiang theroleofprostatitisinprostatecancermetaanalysis AT pumillchris theroleofprostatitisinprostatecancermetaanalysis AT jiangjunyi roleofprostatitisinprostatecancermetaanalysis AT lijinyi roleofprostatitisinprostatecancermetaanalysis AT yunxiazhang roleofprostatitisinprostatecancermetaanalysis AT zhuhong roleofprostatitisinprostatecancermetaanalysis AT liujunjiang roleofprostatitisinprostatecancermetaanalysis AT pumillchris roleofprostatitisinprostatecancermetaanalysis |